Shannon McCurdy is an Oncology physician affiliated with Hospital of the University of Pennsylvania. OpenAlex indexes 150 publications with 3,323 citations (h-index 28); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3400 Civic Center Blvd
12 South
Philadelphia, PA 191045127
Telephone
215-385-2776Provider last certified this registry record 8 Jan 2025.
Clinical trials
- Improve Outcomes for Older Allogeneic Transplant Recipients
Sponsor: Abramson Cancer Center at Penn Medicine
- Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies
Sponsor: Abramson Cancer Center at Penn Medicine
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Geron CorporationProgram year20259 payments
- National Marrow Donor ProgramProgram year20255 payments
- National Marrow Donor ProgramProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
34.4%Kinase inhibitor16.4%Jakafi87%Sprycel6%Tasigna6%Part D<11 patientsInterferon alpha3.3%Pegasys100%Part D<11 patients+ 6 more classes in this area
Cardiovascular
20.4%Statin7%Atorvastatin Calcium51%Pravastatin Sodium18%Rosuvastatin Calcium16%Lovastatin15%Part D<11 patientsBeta blocker4.9%Carvedilol54%Metoprolol Succinate46%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
13.4%H2 blocker3.5%Famotidine100%Part D≥12 patientsCorticosteroid2.5%Prednisone100%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2022–2026 per NIH RePORTER. The latest:
- The Impact of Frailty on Disease Relapse and Therapy Intensity in Older Adults with Acute Myeloid Leukemia: Biomarkers and Treatment Selection
University of Pennsylvania
FY2026$243,000K76AG095109 - The Impact of Frailty on Disease Relapse and Therapy Intensity in Older Adults with Acute Myeloid Leukemia: Biomarkers and Treatment Selection
University of Pennsylvania
FY2025$243,000K76AG095109 - Optimizing Allogeneic Hematopoietic Cell Transplantation for Older Patients with Hematologic Malignancies
University of Pennsylvania
FY2023$162,500R03AG074068
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Allogeneic Hematopoietic Cell Donor Selection: Contemporary Guidelines from the NMDP/CIBMTR
Biology of Blood and Marrow Transplantation
2025 - NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025
Journal of the National Comprehensive Cancer Network
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Mohamed Gad, MD, MPH
Hospital of the University of Pennsylvania
Lawrence Wechsler, MD
Hospital of the University of Pennsylvania
John Hirshfeld, MD
Hospital of the University of Pennsylvania
Noelle Frey, MD
Hospital of the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”